_:n26741e593a124848bd3d7c38414984e6xb1
<http://schema.org/item>
<https://biopharmajournal.com/2020/09/02/oncolytics-biotech-inc-nasdaqoncy-says-the-first-patients-has-been-dosed-in-phase-2-irene-study-of-pelareorep-anti-pd-1-combo-therapy/>